Unifi Inc. 'B' Rating Affirmed; Outlook Revised To Stable From Positive As Rising Costs Wear Down Profits May 12

  • ID: 2127508
  • May 2012
  • Standard & Poors
1 of 3

U.S.-based textile manufacturer and distributor Unifi Inc.'s operating performance and credit measures have weakened more than expected over the past year because of rising polyester raw material costs. We are affirming the 'B' corporate credit rating on Unifi and the 'B+' issue-level rating on the senior secured notes due 2014. We are revising the outlook to stable from positive, as we no longer believe the company will hit our benchmarks for an upgrade. NEW YORK (Standard & Poor's) May 9, 2012--Standard & Poor's Ratings Services today revised its rating outlook on Greensboro, N.C.-based Unifi Inc. to stable from positive. We also affirmed our 'B' corporate credit rating on the company and 'B+' issue-level rating on the company's senior secured notes...

Companies mentioned in this report are: Unifi Inc.
Action: Affirmed
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Unifi Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.